The continuous progression of technology is certainly reflected in US healthcare as new digital solutions are regularly being introduced into the market to support both clinicians and patients. Especially for chronic conditions, like type 2 diabetes, there is a need for more consistent patient-provider communication, assessment, and recommendation, allowing for better patient engagement and self-management. Fortunately, this is becoming a reality with the introduction of new technologies, such as digital therapeutics. Digital therapeutics have the potential to empower patients, prevent complications and, ultimately, augment the real-life value of a medication.
The Center for Medicare & Medicaid Services (CMS) have recently further acknowledged the modernization of healthcare, and more specifically, the development of new digital solutions, issuing final rules in Fall 2018 that describe how clinics can bill for remote patient monitoring activities. These types of solutions are now covered under Medicare’s Chronic Care Remote Physiologic Monitoring (or Remote Patient Monitoring, or RPM) codes. As of January 1, 2019, the following codes have been made effective.